An unintended consequence of Open Payments database, which reveals physician payments from drug companies
Drug companies and medical device manufacturers have long cultivated ties with physicians and hospitals in an effort to promote their wares. This has led to some suspicion that patients may end up with prescriptions for drugs they don’t need or devices they don’t want.
Marcella Alsan and Marianne Wanamaker are recipients of this year’s prestigious Arrow Award from the International Health Economics Associationfor research that shows the health of African-American men was adversely impacted by the Tuskegee syphilis study of the early 20thcentury.
Stanford researchers find that physicians with poor malpractice liability records are no more likely than physicians who did not experience claims to relocate for a fresh start elsewhere. However, they were more likely to cease practice or to shift to smaller practice groups or to solo practice.
Study finds China’s population control policy before the One Child Policy was responsible for 200,000 'Missing Girls'
An estimated 210,000 girls may have “gone missing” due to China’s “Later, Longer, Fewer” campaign, a birth planning policy predating the One Child Policy, according to a new study led by Stanford Health Policy researchers published by the Center for Global Development.
Stanford Health Policy’s Douglas K. Owens was named chair of the U.S. Preventive Services Tasks Force, an independent panel of national experts in prevention and evidence-based medicine that makes health-care recommendations to Congress and the American public.
A new study led by Stanford Health Policy's Tara Templin and the Council on Foreign Relations suggests that a better way to measure the role of democracy in public health is to examine the causes of adult mortality, such as noncommunicable diseases, HIV, cardiovascular disease and transportation injuries. Little international assistance targets these noncommunicable diseases.
A helpful reminder — something as simple as "Are you taking your medications?" — could conceivably prolong a life.
And now, a Stanford study provides novel, concrete evidence on the power of exposure to health-related expertise – not only in improving mortality rates and lifelong health outcomes, but also in narrowing the vexing health gap between the rich and poor.
Stanford Health Policy’s M. Kate Bundorf and Maria Polyakova developed an online decision-support tool to test whether machine-based expert recommendations would influence choice among Medicare Part D enrollees — and make it easier.
New research led by Stanford shows that not only have opioid-related deaths jumped fourfold in the last 20 years, but that those most affected by the epidemic, and where they live, has also shifted dramatically. In fact, the District of Columbia has had the fastest rate of increase in mortality from opioids, more than tripling every year since 2013.
There is little debate over the importance of primary care physicians — the virtual quarterbacks of our medical teams running us toward the end zones in good health. New research now shows us just how important those primary care physicians are in what to many is the most important contest of all: prolonging our lives.
As the price of health care in the United States continues to accelerate — to the consternation of both patients and providers — it’s refreshing to find one state pilot project that appears to prove that implementing mandatory price controls can actually work.
Global study predicts 20-percent rise in insulin use by 2030 — but half the world's diabetics who need it won’t get it
The amount of insulin needed to effectively treat type 2 diabetes will rise by more than 20 percent worldwide over the next 12 years, according to new research led by Stanford Health Policy’s Sanjay Basu.
The Trump administration has proposed a new rule that would require direct-to-consumer TV advertisements for prescription drugs to disclose the price of their products.
The Centers for Medicare & Medicaid Services (CMS) said the disclosures would help consumers “make informed decisions that minimize not only their out-of-pocket costs, but also expenditures borne by Medicare and Medicaid, both of which are significant problems.”
Suhani Jalota was only 20 years old when she established a foundation to help impoverished women in the slums of her native city, Mumbai. She was 23 when Forbes named her one of Asia’s 30-Under-30 Social Entrepreneurs as her foundation was taking off. Now, at the ripe old age of 24, she is embarking on her pursuit of a PhD in health policy on the econ track at Stanford Medicine’s Department of Health Research and Policy.
Research by Stanford Health Policy’s Michelle Mello looks at what happens when a group of hospitals started systematically acknowledging adverse outcomes in care by apologizing and proactively offering compensation where substandard care caused serious harm.